Cargando…

Reasons for Altering Bladder Management and Satisfaction with Current Bladder Management in Chronic Spinal Cord Injury Patients

Patients with spinal cord injury (SCI) often require bladder management. However, patients routinely change their bladder management for better satisfaction. The reasons for altering a bladder management method in SCI patients remain insufficiently understood. The purposes of this study are to asses...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yeh, Hui-Ling, Kuo, Hann-Chorng, Tsai, Chuan-Hsiu, Lee, Ru-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779055/ https://www.ncbi.nlm.nih.gov/pubmed/36554912 http://dx.doi.org/10.3390/ijerph192417032

Ejemplares similares

Satisfaction with Surgical Procedures and Bladder Management of Chronic Spinal Cord Injured Patients with Voiding Dysfunction Who Desire Spontaneous Voiding
por: Wu, Shu-Yu, et al.
Publicado: (2022)

Satisfaction with Detrusor OnabotulinumtoxinA Injections and Conversion to Other Bladder Management in Patients with Chronic Spinal Cord Injury
por: Chen, Sheng-Fu, et al.
Publicado: (2022)

Conservative Bladder Management and Medical Treatment in Chronic Spinal Cord Injury Patients
por: Ong, Hueih Ling, et al.
Publicado: (2023)

Real-World Data Regarding Satisfaction to Botulinum Toxin A Injection into the Urethral Sphincter and Further Bladder Management for Voiding Dysfunction among Patients with Spinal Cord Injury and Voiding Dysfunction
por: Lee, Cheng-Ling, et al.
Publicado: (2022)

Bladder Management Strategies for Urological Complications in Patients with Chronic Spinal Cord Injury
por: Chen, Yu-Chen, et al.
Publicado: (2022)

Will repeated botulinum toxin A improve detrusor overactivity and bladder compliance in patients with chronic spinal cord injury?
por: Chen, Sheng-Fu, et al.
Publicado: (2020)

Current pharmacological and surgical treatment of underactive bladder
por: Jiang, Yuan-Hong, et al.
Publicado: (2017)

Satisfaction with Urinary Incontinence Treatments in Patients with Chronic Spinal Cord Injury
por: Chen, Sheng-Fu, et al.
Publicado: (2022)

Individualizing medical treatment of overactive bladder
por: Kuo, Hann-Chorng
Publicado: (2018)

Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder
por: Chen, Sheng-Fu, et al.
Publicado: (2016)

Predictive Factors for a Satisfactory Treatment Outcome with Intravesical Botulinum Toxin A Injection in Patients with Interstitial Cystitis/Bladder Pain Syndrome
por: Wang, Hsiu-Jen, et al.
Publicado: (2019)

Effects of different urodynamic characteristics on therapeutic outcomes of overactive bladder medication in a real-life clinical practice
por: Wang, Hsiu-Jen, et al.
Publicado: (2021)

Current Understanding of the Pathophysiology and Novel Treatments of Interstitial Cystitis/Bladder Pain Syndrome
por: Jhang, Jia-Fong, et al.
Publicado: (2022)

Possible Association between Bladder Wall Morphological Changes on Computed Tomography and Bladder-Centered Interstitial Cystitis/Bladder Pain Syndrome
por: Jhang, Jia-Fong, et al.
Publicado: (2021)

Bladder and Bowel Management in Dogs With Spinal Cord Injury
por: Granger, Nicolas, et al.
Publicado: (2020)

Inflammation and Barrier Function Deficits in the Bladder Urothelium of Patients with Chronic Spinal Cord Injury and Recurrent Urinary Tract Infections
por: Wu, Shu-Yu, et al.
Publicado: (2022)

Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis—Different Mechanisms of Action of Botox on Bladder Dysfunction?
por: Kuo, Yuh-Chen, et al.
Publicado: (2016)

Use of Urinary Cytokine and Chemokine Levels for Identifying Bladder Conditions and Predicting Treatment Outcomes in Patients with Interstitial Cystitis/Bladder Pain Syndrome
por: Yu, Wan-Ru, et al.
Publicado: (2022)

Discriminating Different Bladder and Bladder Outlet Dysfunctions by Urinary Biomarkers in Women with Frequency–Urgency Syndrome
por: Jhang, Jia-Fong, et al.
Publicado: (2023)

Video-urodynamic characteristics of non-neurogenic, idiopathic underactive bladder in men – A comparison of men with normal tracing and bladder outlet obstruction
por: Jiang, Yuan-Hong, et al.
Publicado: (2017)

Therapeutic Effect of Botulinum Toxin A on Sensory Bladder Disorders—From Bench to Bedside
por: Jiang, Yuan-Hong, et al.
Publicado: (2020)

The Overactive Bladder Symptom Score, International Prostate Symptom Score–Storage Subscore, and Urgency Severity Score in Patients With Overactive Bladder and Hypersensitive Bladder: Which Scoring System is Best?
por: Chuang, Fei-Chi, et al.
Publicado: (2018)

Recurrent urinary tract infection in women and overactive bladder – Is there a relationship?
por: Ke, Qian-Sheng, et al.
Publicado: (2020)

Treating overactive bladder symptoms after transurethral prostatic surgery for benign prostatic hyperplasia – Which medication to choose?
por: Lee, Cheng-Ling, et al.
Publicado: (2023)

Pathomechanism of Interstitial Cystitis/Bladder Pain Syndrome and Mapping the Heterogeneity of Disease
por: Jhang, Jia-Fong, et al.
Publicado: (2016)

Liposome-Encapsulated Botulinum Toxin A in Treatment of Functional Bladder Disorders
por: Hung, Fan-Ching, et al.
Publicado: (2022)

Therapeutic efficacy of mirabegron 25 mg monotherapy in patients with nocturia-predominant hypersensitive bladder
por: Lee, Cheng-Ling, et al.
Publicado: (2019)

Effect of Botulinum Toxin A on Bladder Pain—Molecular Evidence and Animal Studies
por: Yeh, Ting-Chun, et al.
Publicado: (2020)

Usefulness of Urinary Biomarkers for Assessing Bladder Condition and Histopathology in Patients with Interstitial Cystitis/Bladder Pain Syndrome
por: Jiang, Yuan-Hong, et al.
Publicado: (2022)

Treatment Outcomes of Intravesical Botulinum Toxin A Injections on Patients with Interstitial Cystitis/Bladder Pain Syndrome
por: Yu, Wan-Ru, et al.
Publicado: (2022)

Practical Aspects of Botulinum Toxin-A Treatment in Patients With Overactive Bladder Syndrome
por: Liao, Chun-Hou, et al.
Publicado: (2015)

Comparative study of different combinations of mirabegron and antimuscarinics in treatment for overactive bladder syndrome in elderly patients
por: Kuo, Yuh-Chen, et al.
Publicado: (2021)

How to choose appropriate medication for overactive bladder: Findings from the largest integrated clinical trial database analysis of mirabegron studies
por: Kuo, Hann-Chorng
Publicado: (2020)

Bladder management methods and urological complications in spinal cord injury patients
por: Singh, Roop, et al.
Publicado: (2011)

Translating promising strategies for bowel and bladder management in spinal cord injury
por: Wheeler, Tracey L., et al.
Publicado: (2018)

Neurogenic Bladder Physiology, Pathogenesis, and Management after Spinal Cord Injury
por: Perez, Nathalie Elisabeth, et al.
Publicado: (2022)

Long-Term Efficacy and Safety of Repeated Intravescial OnabotulinumtoxinA Injections Plus Hydrodistention in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome
por: Lee, Cheng-Ling, et al.
Publicado: (2015)

Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis
por: Chen, Jing-Liang, et al.
Publicado: (2020)

Efficacy of Intravesical Botulinum Toxin A Injection in the Treatment of Refractory Overactive Bladder in Children
por: Fan, Yu-Hua, et al.
Publicado: (2023)

Ultrastructural changes in the underactive bladder
por: Ho, Han-Chen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f1534njctumbh19uebmrh44ej2